In vivo methods of treatment to prevent kidney dysfunction using

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A67K 3124

Patent

active

060018755

ABSTRACT:
The present invention is directed to the prevention in vivo of the nonenzymatic glycation of albumin, which generates biologically active Amadori glucose adducts in the albumin molecule, as well as methods of using compounds that protect against nonenzymatic glycation in vivo to treat kidney dysfunction.

REFERENCES:
patent: 4060626 (1977-11-01), Hrstka et al.
patent: 5245046 (1993-09-01), Youngdale et al.
EMbase Abstract 92126412 (1992) .cndot.van Boekel et al, 1992.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

In vivo methods of treatment to prevent kidney dysfunction using does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with In vivo methods of treatment to prevent kidney dysfunction using, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and In vivo methods of treatment to prevent kidney dysfunction using will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-863931

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.